We can't find the internet
Attempting to reconnect
14438.1;7 PFLS-LS
Profiling of Synthetic Virus-like Nanoparticle Pneumococcal Vaccine Candidates
Zusammenfassung
Profiling of Synthetic Virus-like Nanoparticle Pneumococcal Vaccine Candidates
Weitere Texte
Abstract
Virometix AG is developing a broad-spectrum pneumococcal vaccine based on its synthetic virus-like particle (SVLP) technology, comprising surface proteins (virulence factors) that are commonly expressed by all pneumococcal serotypes. The vaccine should overcome major shortcomings of the current capsular polysaccharide-based vaccines including limited serotype coverage and high manufacturing complexity. This KTI project should support preclinical profiling of Virometix vaccine candidates in animal models of pneumococcal diseases.
Beteiligte
John A. Robinson
Kontaktperson
robinson@oci.uzh.ch
Universität Zürich Organisch-chemisches Institut John A. Robinson Winterthurerstr. 190 8057 Zürich ZH CH
Projektdetails
- Forschungsstelle
- INNOSUISSE
- Projektstatus
- Abgeschlossen
- Projekttyp
- Forschungsprojekt
- Startdatum
- 2012-08-31
- Enddatum
- 2014-09-08
- Bewilligte Gesamtkosten
- CHF 400000.00
- Sektion
- 20 Förderbereich Life Sciences
- NABS Politikbereich
- Nicht aufteilbare / nicht zuteilbare Forschung
Forschungsdisziplinen
- T490 Biotechnology 100.0%